Asia Pacific Biodefense Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Anthrax, Small pox, Botulism, Radiation/Nuclear, Others), and Geography

No. of Pages: 100    |    Report Code: TIPRE00010409    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Biodefense Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Biodefense market – By Product

1.3.2        Asia Pacific Biodefense market – By Country

2.           Asia Pacific Biodefense market –  Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia Pacific Biodefense market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        4.2.1 Biodefense market - Asia Pacific PEST Analysis

4.3         Expert Opinion

5.           Asia Pacific Biodefense market -  Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Presence of Favourable Government Initiatives

5.1.2        Increase in the Number of Naturally Occurring Outbreaks

5.1.3        Increasing Threat of Biological Weapons and Nuclear Armed ICBM

5.2         Key Market Restraints

5.2.1        Low R&D Funding by Government in Developing and Underdeveloped Economies

5.3         Key Market Opportunities

5.3.1        Increased Adoption of Technologies

5.4         Future Trends

5.4.1        Predictive Analytics to Reshape Biodefense Market

5.5         Impact Analysis

6.           Biodefense market – Asia Pacific Analysis

6.1         Asia Pacific Biodefense market Revenue Forecasts and Analysis

7.           Asia Pacific Biodefense market Analysis And Forecasts To 2027 – By Product

7.1         Overview

7.2         Asia Pacific Biodefense market, By Product 2019 & 2027 (%)

7.2.1        Asia Pacific Biodefense market Revenue and Forecasts to 2027, By Product (US$ Mn)

7.3         Anthrax

7.3.1        Overview

7.3.2        Asia Pacific Anthrax Market Revenue and Forecast to 2027 (US$ Mn)

7.4         Small pox

7.4.1        Overview

7.4.2        Asia Pacific Small Pox Market Revenue and Forecasts to 2027 (US$ Mn)

7.5         Botulism

7.5.1        Overview

7.5.2        Asia Pacific Botulism Market Revenue and Forecasts to 2027 (US$ Mn)

7.6         Radiation/Nuclear

7.6.1        Overview

7.6.2        Asia Pacific Radiation/Nuclear Market Revenue and Forecasts to 2027 (US$ Mn)

7.7         Others

7.7.1        Overview

7.7.2        Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)

8.           Biodefense market Revenue and Forecasts To 2027 – Geographical Analysis

8.1         Asia Pacific Biodefense market Revenue and Forecasts To 2027

8.1.1        Overview

8.1.2        Asia Pacific: Biodefense Market - Revenue and Forecast to 2027 (USD Million)

8.1.3        Asia Pacific: Biodefense Market, by Product, 2018–2027 (USD Million)

8.1.4        Asia Pacific: Biodefense Market, by Country, 2018 & 2027 (%)

8.1.5        China: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.5.1          China: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.5.2          China: Biodefense Market, by Product Type, 2018–2027 (USD Million)

8.1.6        Japan: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.6.1          Japan: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.6.2          Japan: Biodefense Market, by Product Type, 2018–2027 (USD Million)

8.1.7        India: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.7.1          India: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.7.2          India: Biodefense Market, by Product Type, 2018–2027 (USD Million)

8.1.8        South Korea: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.8.1          South Korea: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.8.2          South Korea: Biodefense Market, by Product Type, 2018–2027 (USD Million)

8.1.9        Australia: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.9.1          Australia: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.9.2          Australia: Biodefense Market, by Product Type, 2018–2027 (USD Million)

9.           Impact of Covid-19 Pandemic On Asia Pacific Biodefense Market

9.1         Asia-Pacific: Impact assessment of COVID-19 Pandemic

10.        Asia Pacific Biodefense market Industry Landscape

10.1      Overview

10.2      Growth Strategies in The Biodefense Market, 2016-2020

10.3      Inorganic Growth Strategies

10.3.1     Overview

10.4      Organic Growth Strategies

10.4.1     Overview

11.        COMPANY PROFILES

11.1      Bavarian Nordic

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      Alnylam Pharmaceuticals, Inc.

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      SIGA Technologies

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Emergent BioSolutions Inc.

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      Cleveland Bio Labs

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

12.        Appendix

12.1      About The Insight Partners

12.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             Asia Pacific Biodefense market Revenue and Forecasts To 2027, By Product (US$ Mn)

Table 2.             Asia Pacific Biodefense Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 3.             China Biodefense Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 4.             Japan Biodefense Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 5.             India Biodefense Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 6.             South Korea Biodefense Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 7.             Australia Biodefense Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 8.             Recent Inorganic Growth Strategies In The Biodefense Market

Table 9.             Recent Organic Growth Strategies In The Biodefense Market

Table 10.          Glossary of Terms, Skin aesthetic devices market

 


LIST OF FIGURES

Figure 1.           Biodefense market Segmentation

Figure 2.           Asia Pacific Biodefense market Overview

Figure 3.           Anthrax Segment Held Largest Share of Product Segment in Biodefense Market

Figure 4.           Japan is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Asia Pacific Biodefense market- Leading Country Markets (US$ Mn)

Figure 6.           Asia Pacific Biodefense market, Industry Landscape

Figure 7.           Biodefense market - Asia Pacific PEST Analysis

Figure 8.           Biodefense market Impact Analysis of Drivers and Restraints

Figure 9.           Asia Pacific Biodefense market – Revenue Forecasts and Analysis – 2019- 2027

Figure 10.        Asia Pacific Biodefense market, By Product 2019 & 2027 (%)

Figure 11.        Asia Pacific Anthrax Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        Asia Pacific Small Pox Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.        Asia Pacific Botulism Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.        Asia Pacific Radiation/Nuclear Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.        Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.        Asia Pacific: Biodefense Market, by Key Country – Revenue (2019) (USD Million)

Figure 17.        Asia Pacific Biodefense Market Revenue and Forecast to 2027 (USD Million)

Figure 18.        China: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

Figure 19.        Japan: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

Figure 20.        India: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

Figure 21.        South Korea: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

Figure 22.        Australia: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

Figure 23.        Impact Of Covid-19 Pandemic In Asia Pacific Country Markets

Figure 24.        Growth Strategies in the Biodefense Market, 2016-2020

 

The List of Companies - Asia Pacific Biodefense Market

The List of Companies - Asia Pacific Biodefense Market

  1. Bavarian Nordic
  2. Alnylam Pharmaceuticals, Inc.
  3. SIGA Technologies
  4. Emergent BioSolutions Inc.
  5. Cleveland Bio Labs
  6. Dynavax Technologies
  7. Elusys Therapeutics, Inc.
  8. Soligenix
  9. Altimmune
  10. Pluristem Therapeutics